Drugs / XOMA 3AB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01357213 | May 2011 → May 2012 | botulism | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XOMA 3AB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01357213 ↗ |
| Modality | Monoclonal antibody | “a combination of three anti-botulinum monoclonal antibodies will be evaluated” NCT01357213 ↗ |
| Route | Intravenous | “single intravenous infusion of XOMA 3AB” NCT01357213 ↗ |